Novo Nordisk | NVO - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Bausch Health Companies USD 593M 0 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Drreddys Laboratories INR 22.36B 21.91B 2026-03
Eli Lilly USD 6.11B 1.08B 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Novartis USD 4.26B 64M 2026-06
Novo Nordisk DKK 14.59B 212M 2026-06
Novo Nordisk DKK 2.23B 131.82B 2026-06
Pacira USD 17.51M 3.5M 2026-06
Perrigo USD 400.4M 34.4M 2026-06
Phibro Animal Health USD 127.31M 2.33M 2026-06
Prestige Brands USD 36.85M 14.06M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
Zoetis USD 452M 55M 2026-06